Literature DB >> 25390780

Bilateral circumscribed choroidal hemangioma in an otherwise healthy individual.

Hoai Viet Tran1, Ann Schalenbourg, Leonidas Zografos.   

Abstract

PURPOSE: To describe an extremely rare association of bilateral circumscribed hemangioma (CCH) in the absence of any other evidence of systemic abnormalities.
METHODS: A 43-year-old man was referred to our institution with a diagnosis of probable unilateral hemangioma of the right eye with decreased visual acuity.
RESULTS: Funduscopic examination of both eyes revealed one CCH in each eye. Fluorescein angiography, indocyanine green angiography, and A- and B-scan ultrasonography confirmed the diagnosis. General examination, endocrinological testing, and imagery workup did not show any abnormality. The right eye was treated with low-dose external-beam irradiation with complete recovery of visual acuity.
CONCLUSION: Bilateral choroidal localization of tumoral lesions raises the question about their primary or metastatic onset. To our knowledge, bilateral CCH has been reported only in association with Sturge-Weber or Klippel-Trénaunay-Weber syndrome. The bilateral CCH localization in a healthy individual represents an extremely uncommon condition, which may represent a low penetrance phenotype of Sturge-Weber syndrome.

Entities:  

Year:  2007        PMID: 25390780     DOI: 10.1097/01.ICB.0000279646.84077.b4

Source DB:  PubMed          Journal:  Retin Cases Brief Rep        ISSN: 1935-1089


  3 in total

1.  Multifocal circumscribed choroidal hemangioma: a rare occurrence.

Authors:  Vijitha S Vempuluru; Swathi Kaliki
Journal:  BMJ Case Rep       Date:  2020-02-05

2.  Circumscribed choroidal haemangioma: clinical and topographical features.

Authors:  Jørgen Krohn; Pukhraj Rishi; Torbjørn Frøystein; Arun D Singh
Journal:  Br J Ophthalmol       Date:  2019-01-02       Impact factor: 4.638

Review 3.  Circumscribed choroidal hemangioma: An overview of clinical manifestation, diagnosis and management.

Authors:  Mrittika Sen; Santosh G Honavar
Journal:  Indian J Ophthalmol       Date:  2019-12       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.